manag guid street remain overweight
continu favor share follow beat posit guid
midpoint ep rang street expect model
midpoint manag spoke difficult comp companion anim dermatolog
product specif us growth expect continu albeit mute
growth opportun product regist region
china livestock domest intern perform expect
expect continu strength favor livestock fundament driven strong
demand low input cost produc feed fundament grant
favor last year across speci herd still expect y/i drive
increas anim health usag use previou valuat methodolog
ep price target move remain overweight
anoth beat rais manag continu execut beat consensu
guidanc expect revenu came street adjust
ep beat street expect ep also top
full-year guidanc rang strength quarter driven livestock
us intern grew faster expect strength intern
companion anim help off-set lower-than-expect growth us companion
seem zoeti diversif across speci region continu drive growth
seen view key differenti companion anim
strong growth continu dermatolog product in-lin portfolio seem
flat experienc outsiz competit headwind us strength beef
drove livestock growth swine also favor intern livestock
market growth key region like brazil china remain strong
lift estim target make modest adjust model due
manag posit guid adjust ep rang
cent midpoint herd across key speci expect
year believ growth us livestock anim health continu
strong although manag expect potenti weak dairi given
lower milk price y/i still yet hear signific cull manag believ
intern livestock market continu strong model
anoth year mid-single-digit growth livestock grant modestli lower compar
growth companion anim growth expect moder compar
given difficult comp grow dermatolog product still model
low-double-digit growth albeit slower growth year new product
offer diagnost expect drive long-term growth visibl
opportun still remain rel low ep move
acquisit integr competit fx macro econom factor
zoeti lead global manufactur anim health medic vaccin
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
million except per share data
current disclosur inform compani found http //www piperjaffray com/researchdisclosur
sale
amort intang
net incom loss attribut non-controlling interest
net incom attribut zoeti
adjust report ep
depreci amort
net incom attribut zoeti
page
million except per share
total revenu speci
fish sheep
dog
revenu composit speci
fish sheep
dog
fish sheep
dog
page
million except per share
cash equival
receiv pfizer
properti plant equip
current portion alloc long-term debt
payabl pfizer
accru compens relat item
equiti attribut non-controlling interest
page
statement flow
million except per share
depreci amort
asset-write-off impair
net gain sale asset
chang asset liabil
total chang asset liabil
purchas properti plant equip
net proce sale asset
acquisit net cash acquir
increas short-term borrow net
purchas treasuri stock
issuanc long-term debt
payment pfizer
payment long-term debt
purchas subsidiari share
net financ activ pfizer
effect exchang rate chang
net increas cash cash equival
page
